Precision Medicine Group to rack up $275 mln

Berkshire Partners and TPG Growth has agreed to lead a $275 million funding round for Bethesda, Maryland-based Precision Medicine Group, a provider of an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products. Other investors include Oak Investment Partners and J.H. Whitney.

DealsNorth AmericaUSHealthcareBriefs